Gene Symbol | Gene ID | Gene Info |
---|---|---|
NFATC2
|
ENSG00000101096.15 | nuclear factor of activated T cells 2 |
NFATC3
|
ENSG00000072736.14 | nuclear factor of activated T cells 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr20_50182108_50182395 | NFATC2 | 2881 | 0.381143 | 0.91 | 6.2e-04 | Click! |
chr20_50182582_50182741 | NFATC2 | 3291 | 0.361160 | 0.85 | 4.0e-03 | Click! |
chr20_50148880_50149119 | NFATC2 | 10259 | 0.276568 | 0.79 | 1.2e-02 | Click! |
chr20_50178264_50178663 | NFATC2 | 705 | 0.793500 | 0.78 | 1.4e-02 | Click! |
chr20_50177633_50177811 | NFATC2 | 1446 | 0.554501 | 0.77 | 1.5e-02 | Click! |
chr16_68113033_68113320 | NFATC3 | 6071 | 0.111163 | -0.70 | 3.6e-02 | Click! |
chr16_68116781_68116932 | NFATC3 | 2391 | 0.168951 | -0.55 | 1.2e-01 | Click! |
chr16_68114330_68114481 | NFATC3 | 4842 | 0.118295 | -0.51 | 1.6e-01 | Click! |
chr16_68118751_68118972 | NFATC3 | 386 | 0.755604 | -0.47 | 2.0e-01 | Click! |
chr16_68113803_68114150 | NFATC3 | 5271 | 0.115338 | -0.45 | 2.2e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_163099691_163099877 | 0.96 |
FAP |
fibroblast activation protein, alpha |
182 |
0.96 |
chr13_76211856_76212147 | 0.92 |
LMO7 |
LIM domain 7 |
1542 |
0.32 |
chr8_93074610_93074813 | 0.90 |
RUNX1T1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
480 |
0.89 |
chr6_35182117_35182910 | 0.78 |
SCUBE3 |
signal peptide, CUB domain, EGF-like 3 |
317 |
0.9 |
chr12_76422291_76422442 | 0.77 |
RP11-290L1.3 |
|
1908 |
0.31 |
chr13_76212170_76212445 | 0.76 |
LMO7 |
LIM domain 7 |
1848 |
0.28 |
chr8_93113958_93114847 | 0.72 |
RUNX1T1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
1052 |
0.69 |
chr2_222366683_222366911 | 0.72 |
EPHA4 |
EPH receptor A4 |
483 |
0.85 |
chr13_40174017_40174396 | 0.69 |
LHFP |
lipoma HMGIC fusion partner |
3102 |
0.29 |
chr9_129883603_129883754 | 0.69 |
ANGPTL2 |
angiopoietin-like 2 |
1235 |
0.56 |
chr3_120167855_120168016 | 0.67 |
FSTL1 |
follistatin-like 1 |
1903 |
0.44 |
chr9_117879769_117880175 | 0.66 |
TNC |
tenascin C |
506 |
0.85 |
chr19_16404198_16404375 | 0.65 |
CTD-2562J15.6 |
|
100 |
0.96 |
chr2_216296824_216297216 | 0.61 |
FN1 |
fibronectin 1 |
3770 |
0.26 |
chr3_99357829_99358140 | 0.59 |
COL8A1 |
collagen, type VIII, alpha 1 |
530 |
0.85 |
chr8_52438263_52438652 | 0.58 |
PXDNL |
peroxidasin homolog (Drosophila)-like |
116918 |
0.07 |
chr2_198540036_198540213 | 0.57 |
RFTN2 |
raftlin family member 2 |
595 |
0.74 |
chr3_134092531_134092774 | 0.56 |
AMOTL2 |
angiomotin like 2 |
13 |
0.98 |
chr11_8831505_8831934 | 0.56 |
ST5 |
suppression of tumorigenicity 5 |
477 |
0.76 |
chr6_169652381_169652976 | 0.56 |
THBS2 |
thrombospondin 2 |
432 |
0.89 |
chr13_24121492_24121736 | 0.56 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
22895 |
0.25 |
chr15_48933837_48934008 | 0.55 |
FBN1 |
fibrillin 1 |
3996 |
0.32 |
chr7_94027064_94027257 | 0.54 |
COL1A2 |
collagen, type I, alpha 2 |
3287 |
0.35 |
chr2_238322401_238322657 | 0.54 |
COL6A3 |
collagen, type VI, alpha 3 |
262 |
0.93 |
chr6_150176715_150177267 | 0.54 |
RP11-350J20.12 |
|
3393 |
0.15 |
chr19_58566444_58566629 | 0.54 |
ZNF135 |
zinc finger protein 135 |
4071 |
0.14 |
chr20_19956550_19956867 | 0.53 |
NAA20 |
N(alpha)-acetyltransferase 20, NatB catalytic subunit |
41052 |
0.15 |
chr16_85205777_85205989 | 0.52 |
CTC-786C10.1 |
|
1001 |
0.63 |
chr1_153584420_153584625 | 0.52 |
S100A16 |
S100 calcium binding protein A16 |
1037 |
0.29 |
chr11_119292436_119293234 | 0.52 |
THY1 |
Thy-1 cell surface antigen |
437 |
0.74 |
chr8_135469745_135470192 | 0.51 |
ZFAT |
zinc finger and AT hook domain containing |
52457 |
0.18 |
chr22_18051179_18051572 | 0.51 |
SLC25A18 |
solute carrier family 25 (glutamate carrier), member 18 |
8225 |
0.18 |
chr16_31007794_31008230 | 0.51 |
STX1B |
syntaxin 1B |
4264 |
0.1 |
chr3_100701853_100702007 | 0.51 |
ABI3BP |
ABI family, member 3 (NESH) binding protein |
10367 |
0.25 |
chr7_45961953_45962825 | 0.51 |
IGFBP3 |
insulin-like growth factor binding protein 3 |
916 |
0.6 |
chr19_18761571_18761809 | 0.51 |
KLHL26 |
kelch-like family member 26 |
13823 |
0.1 |
chr5_54456050_54456451 | 0.50 |
GPX8 |
glutathione peroxidase 8 (putative) |
252 |
0.86 |
chr10_124222527_124222791 | 0.50 |
HTRA1 |
HtrA serine peptidase 1 |
1618 |
0.37 |
chr18_54070586_54070808 | 0.50 |
TXNL1 |
thioredoxin-like 1 |
211025 |
0.02 |
chr1_25525492_25525809 | 0.50 |
RP4-706G24.1 |
|
8980 |
0.19 |
chr10_63213041_63213324 | 0.50 |
TMEM26 |
transmembrane protein 26 |
26 |
0.95 |
chr11_128321481_128322071 | 0.50 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
53513 |
0.16 |
chr1_162601787_162601952 | 0.50 |
DDR2 |
discoidin domain receptor tyrosine kinase 2 |
68 |
0.98 |
chr9_112543013_112543264 | 0.49 |
AKAP2 |
A kinase (PRKA) anchor protein 2 |
369 |
0.36 |
chr11_101982396_101983287 | 0.48 |
YAP1 |
Yes-associated protein 1 |
404 |
0.82 |
chr2_163099011_163099583 | 0.48 |
FAP |
fibroblast activation protein, alpha |
261 |
0.94 |
chr5_121412020_121412268 | 0.48 |
LOX |
lysyl oxidase |
1836 |
0.4 |
chr5_72416676_72417048 | 0.48 |
TMEM171 |
transmembrane protein 171 |
466 |
0.79 |
chr7_94034050_94034201 | 0.48 |
COL1A2 |
collagen, type I, alpha 2 |
10252 |
0.27 |
chr4_114680063_114680214 | 0.48 |
CAMK2D |
calcium/calmodulin-dependent protein kinase II delta |
2086 |
0.48 |
chr17_48274536_48274705 | 0.48 |
COL1A1 |
collagen, type I, alpha 1 |
2932 |
0.16 |
chr4_152146952_152147499 | 0.47 |
SH3D19 |
SH3 domain containing 19 |
7 |
0.98 |
chr21_17960305_17960805 | 0.47 |
ENSG00000207863 |
. |
2002 |
0.4 |
chr4_81191707_81191903 | 0.47 |
FGF5 |
fibroblast growth factor 5 |
4012 |
0.29 |
chr2_145780897_145781240 | 0.46 |
ENSG00000253036 |
. |
311570 |
0.01 |
chr2_109271526_109272143 | 0.46 |
LIMS1 |
LIM and senescent cell antigen-like domains 1 |
325 |
0.91 |
chr7_19145822_19145973 | 0.46 |
AC003986.6 |
|
6200 |
0.17 |
chr2_192111446_192111930 | 0.46 |
MYO1B |
myosin IB |
679 |
0.79 |
chr6_28952769_28953226 | 0.46 |
HCG15 |
HLA complex group 15 (non-protein coding) |
983 |
0.36 |
chr6_82316955_82317252 | 0.46 |
ENSG00000212336 |
. |
14814 |
0.23 |
chr6_148831295_148831530 | 0.46 |
ENSG00000223322 |
. |
13964 |
0.3 |
chr2_110656312_110656910 | 0.46 |
LIMS3 |
LIM and senescent cell antigen-like domains 3 |
343 |
0.93 |
chr22_45899514_45899973 | 0.45 |
FBLN1 |
fibulin 1 |
817 |
0.67 |
chr1_115879628_115879779 | 0.45 |
NGF |
nerve growth factor (beta polypeptide) |
1154 |
0.6 |
chr9_112832298_112832467 | 0.45 |
AKAP2 |
A kinase (PRKA) anchor protein 2 |
20095 |
0.26 |
chr15_81073681_81073832 | 0.45 |
KIAA1199 |
KIAA1199 |
2044 |
0.37 |
chr18_66465448_66465631 | 0.45 |
CCDC102B |
coiled-coil domain containing 102B |
113 |
0.97 |
chr4_81192022_81192173 | 0.44 |
FGF5 |
fibroblast growth factor 5 |
4304 |
0.29 |
chr3_25469138_25469713 | 0.44 |
RARB |
retinoic acid receptor, beta |
329 |
0.93 |
chr5_38810138_38810320 | 0.44 |
RP11-122C5.3 |
|
26547 |
0.21 |
chr21_28335462_28335613 | 0.44 |
ADAMTS5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
3295 |
0.28 |
chr8_17554662_17554991 | 0.43 |
MTUS1 |
microtubule associated tumor suppressor 1 |
353 |
0.86 |
chr6_131291045_131291463 | 0.43 |
EPB41L2 |
erythrocyte membrane protein band 4.1-like 2 |
369 |
0.93 |
chr11_12696722_12697409 | 0.43 |
TEAD1 |
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
15 |
0.99 |
chr8_104090727_104091208 | 0.43 |
ENSG00000265667 |
. |
13982 |
0.15 |
chr9_112543764_112544054 | 0.43 |
AKAP2 |
A kinase (PRKA) anchor protein 2 |
1140 |
0.28 |
chr1_150245669_150245859 | 0.43 |
C1orf54 |
chromosome 1 open reading frame 54 |
581 |
0.54 |
chr20_48183714_48183871 | 0.43 |
PTGIS |
prostaglandin I2 (prostacyclin) synthase |
891 |
0.63 |
chr10_95239483_95239707 | 0.43 |
MYOF |
myoferlin |
2356 |
0.29 |
chr11_114168914_114169158 | 0.43 |
NNMT |
nicotinamide N-methyltransferase |
163 |
0.96 |
chr1_101187273_101187487 | 0.42 |
VCAM1 |
vascular cell adhesion molecule 1 |
2060 |
0.43 |
chr14_52519313_52519627 | 0.42 |
NID2 |
nidogen 2 (osteonidogen) |
13800 |
0.2 |
chr3_99593193_99593490 | 0.42 |
FILIP1L |
filamin A interacting protein 1-like |
1607 |
0.48 |
chr20_43211779_43211930 | 0.42 |
PKIG |
protein kinase (cAMP-dependent, catalytic) inhibitor gamma |
664 |
0.66 |
chr6_152084748_152085135 | 0.42 |
ESR1 |
estrogen receptor 1 |
40625 |
0.17 |
chr3_138893153_138893304 | 0.41 |
MRPS22 |
mitochondrial ribosomal protein S22 |
63982 |
0.12 |
chr12_76420581_76421103 | 0.41 |
RP11-290L1.3 |
|
3432 |
0.23 |
chr8_25488703_25488854 | 0.41 |
CDCA2 |
cell division cycle associated 2 |
172063 |
0.03 |
chr15_70994402_70994652 | 0.41 |
UACA |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
93 |
0.98 |
chr17_18647401_18647567 | 0.41 |
FBXW10 |
F-box and WD repeat domain containing 10 |
96 |
0.96 |
chr5_140181042_140181198 | 0.41 |
PCDHA3 |
protocadherin alpha 3 |
337 |
0.71 |
chr2_111229826_111230082 | 0.41 |
LIMS3 |
LIM and senescent cell antigen-like-containing domain protein 3; Uncharacterized protein; cDNA FLJ59124, highly similar to Particularly interesting newCys-His protein; cDNA, FLJ79109, highly similar to Particularly interesting newCys-His protein |
439 |
0.46 |
chr9_112259733_112260156 | 0.41 |
PTPN3 |
protein tyrosine phosphatase, non-receptor type 3 |
642 |
0.76 |
chr1_231002889_231003524 | 0.41 |
C1orf198 |
chromosome 1 open reading frame 198 |
1193 |
0.37 |
chr3_138957249_138957403 | 0.40 |
MRPS22 |
mitochondrial ribosomal protein S22 |
105535 |
0.06 |
chrX_34672609_34672760 | 0.40 |
TMEM47 |
transmembrane protein 47 |
2721 |
0.44 |
chr1_107684993_107685186 | 0.40 |
NTNG1 |
netrin G1 |
1428 |
0.58 |
chr5_141980216_141980760 | 0.40 |
AC005592.2 |
|
19075 |
0.18 |
chr8_77594044_77594273 | 0.40 |
ZFHX4 |
zinc finger homeobox 4 |
604 |
0.67 |
chr10_73725086_73725706 | 0.40 |
CHST3 |
carbohydrate (chondroitin 6) sulfotransferase 3 |
1273 |
0.55 |
chr4_114898431_114898582 | 0.40 |
ARSJ |
arylsulfatase family, member J |
1646 |
0.49 |
chr6_3825964_3826270 | 0.40 |
RP11-420L9.4 |
|
6050 |
0.22 |
chr5_95068778_95068929 | 0.40 |
CTD-2154I11.2 |
|
854 |
0.53 |
chr2_216299376_216299642 | 0.40 |
FN1 |
fibronectin 1 |
1281 |
0.4 |
chr6_85896028_85896266 | 0.40 |
NT5E |
5'-nucleotidase, ecto (CD73) |
263662 |
0.02 |
chr10_13748985_13749251 | 0.40 |
ENSG00000222235 |
. |
2140 |
0.21 |
chr1_8194377_8194540 | 0.40 |
ENSG00000200975 |
. |
72199 |
0.1 |
chr12_105776449_105776971 | 0.39 |
C12orf75 |
chromosome 12 open reading frame 75 |
52064 |
0.13 |
chr4_170188672_170188986 | 0.39 |
SH3RF1 |
SH3 domain containing ring finger 1 |
2279 |
0.41 |
chr8_92612283_92612746 | 0.39 |
ENSG00000200151 |
. |
5321 |
0.33 |
chr17_80806215_80806449 | 0.39 |
ZNF750 |
zinc finger protein 750 |
7878 |
0.16 |
chr4_111397812_111398104 | 0.39 |
ENPEP |
glutamyl aminopeptidase (aminopeptidase A) |
729 |
0.72 |
chr16_88337543_88337778 | 0.39 |
ZNF469 |
zinc finger protein 469 |
156219 |
0.03 |
chr17_42637074_42637426 | 0.39 |
FZD2 |
frizzled family receptor 2 |
2325 |
0.29 |
chr12_115119392_115119718 | 0.39 |
TBX3 |
T-box 3 |
1840 |
0.39 |
chr16_21199797_21200120 | 0.39 |
AF001550.7 |
|
6210 |
0.15 |
chr17_15522812_15523031 | 0.39 |
CDRT1 |
CMT1A duplicated region transcript 1 |
95 |
0.95 |
chr4_20252886_20253037 | 0.38 |
SLIT2 |
slit homolog 2 (Drosophila) |
1922 |
0.5 |
chr19_17354905_17355140 | 0.38 |
NR2F6 |
nuclear receptor subfamily 2, group F, member 6 |
291 |
0.77 |
chr12_7037386_7038830 | 0.38 |
ATN1 |
atrophin 1 |
632 |
0.41 |
chr1_240760211_240760638 | 0.38 |
RP11-467I20.6 |
|
6376 |
0.21 |
chr2_238323039_238323190 | 0.38 |
COL6A3 |
collagen, type VI, alpha 3 |
96 |
0.97 |
chr4_114679395_114679686 | 0.38 |
CAMK2D |
calcium/calmodulin-dependent protein kinase II delta |
2684 |
0.42 |
chr12_126978117_126978628 | 0.38 |
ENSG00000239776 |
. |
672300 |
0.0 |
chr2_48794075_48794240 | 0.38 |
STON1-GTF2A1L |
STON1-GTF2A1L readthrough |
2002 |
0.34 |
chr8_13132829_13133895 | 0.38 |
DLC1 |
deleted in liver cancer 1 |
693 |
0.78 |
chr6_166260281_166260471 | 0.37 |
SDIM1 |
stress responsive DNAJB4 interacting membrane protein 1 |
49349 |
0.16 |
chr2_235890317_235890698 | 0.37 |
SH3BP4 |
SH3-domain binding protein 4 |
239 |
0.97 |
chr10_30344542_30344726 | 0.37 |
KIAA1462 |
KIAA1462 |
3819 |
0.36 |
chr16_51184162_51184313 | 0.37 |
SALL1 |
spalt-like transcription factor 1 |
271 |
0.87 |
chr2_183901778_183902686 | 0.37 |
NCKAP1 |
NCK-associated protein 1 |
968 |
0.52 |
chr5_119542834_119542985 | 0.37 |
ENSG00000251975 |
. |
130439 |
0.06 |
chr4_81187181_81187534 | 0.37 |
FGF5 |
fibroblast growth factor 5 |
396 |
0.89 |
chr11_14467853_14468182 | 0.37 |
ENSG00000251991 |
. |
32421 |
0.18 |
chr5_166478467_166478618 | 0.37 |
TENM2 |
teneurin transmembrane protein 2 |
233262 |
0.02 |
chr1_170638728_170639131 | 0.37 |
PRRX1 |
paired related homeobox 1 |
5851 |
0.31 |
chr14_24803093_24804202 | 0.37 |
ADCY4 |
adenylate cyclase 4 |
306 |
0.72 |
chr1_85065027_85065219 | 0.37 |
CTBS |
chitobiase, di-N-acetyl- |
24976 |
0.17 |
chr12_116872831_116873001 | 0.37 |
ENSG00000264037 |
. |
6793 |
0.3 |
chr16_75298860_75299117 | 0.37 |
BCAR1 |
breast cancer anti-estrogen resistance 1 |
125 |
0.95 |
chr16_4069505_4069681 | 0.37 |
RP11-462G12.4 |
|
12420 |
0.19 |
chr19_39465324_39465724 | 0.37 |
FBXO17 |
F-box protein 17 |
1026 |
0.37 |
chr15_48010079_48010356 | 0.37 |
SEMA6D |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
441 |
0.9 |
chrX_38079311_38080259 | 0.37 |
SRPX |
sushi-repeat containing protein, X-linked |
367 |
0.75 |
chr7_27217830_27218176 | 0.37 |
RP1-170O19.20 |
Uncharacterized protein |
1629 |
0.13 |
chr12_79258716_79258905 | 0.36 |
SYT1 |
synaptotagmin I |
218 |
0.97 |
chr4_66534785_66535387 | 0.36 |
EPHA5 |
EPH receptor A5 |
567 |
0.87 |
chr19_11650036_11650336 | 0.36 |
CNN1 |
calponin 1, basic, smooth muscle |
332 |
0.77 |
chr15_64539202_64539402 | 0.36 |
PPIB |
peptidylprolyl isomerase B (cyclophilin B) |
83898 |
0.06 |
chr10_5670540_5670695 | 0.36 |
ENSG00000240577 |
. |
2809 |
0.25 |
chr13_111452203_111452465 | 0.36 |
LINC00346 |
long intergenic non-protein coding RNA 346 |
69828 |
0.1 |
chrX_90690422_90690847 | 0.36 |
PABPC5-AS1 |
PABPC5 antisense RNA 1 |
636 |
0.54 |
chr18_31336109_31336260 | 0.36 |
ASXL3 |
additional sex combs like 3 (Drosophila) |
150634 |
0.04 |
chr1_161932087_161932899 | 0.36 |
OLFML2B |
olfactomedin-like 2B |
22529 |
0.22 |
chr17_2116897_2117048 | 0.36 |
AC090617.1 |
|
19 |
0.91 |
chr18_73977798_73978026 | 0.36 |
RP11-94B19.4 |
Uncharacterized protein |
6791 |
0.3 |
chr3_149374149_149374556 | 0.36 |
WWTR1-AS1 |
WWTR1 antisense RNA 1 |
455 |
0.65 |
chr12_51180314_51180560 | 0.36 |
ATF1 |
activating transcription factor 1 |
22145 |
0.16 |
chr1_157980874_157981318 | 0.36 |
KIRREL-IT1 |
KIRREL intronic transcript 1 (non-protein coding) |
14244 |
0.2 |
chr13_111049575_111050268 | 0.36 |
ENSG00000238629 |
. |
16631 |
0.22 |
chr12_91570174_91570436 | 0.36 |
DCN |
decorin |
2024 |
0.44 |
chr3_86894495_86894646 | 0.35 |
VGLL3 |
vestigial like 3 (Drosophila) |
145282 |
0.05 |
chr3_72938009_72938232 | 0.35 |
GXYLT2 |
glucoside xylosyltransferase 2 |
896 |
0.65 |
chr6_27205685_27206711 | 0.35 |
PRSS16 |
protease, serine, 16 (thymus) |
9282 |
0.19 |
chr3_124839242_124839433 | 0.35 |
SLC12A8 |
solute carrier family 12, member 8 |
361 |
0.8 |
chr6_122364269_122364606 | 0.35 |
ENSG00000199932 |
. |
168357 |
0.04 |
chr10_29923091_29923260 | 0.35 |
SVIL |
supervillin |
726 |
0.71 |
chr15_89347709_89348117 | 0.35 |
ACAN |
aggrecan |
923 |
0.66 |
chr16_22436171_22436423 | 0.35 |
CDR2 |
cerebellar degeneration-related protein 2, 62kDa |
6620 |
0.14 |
chr2_19556403_19556607 | 0.35 |
OSR1 |
odd-skipped related transciption factor 1 |
172 |
0.97 |
chr7_27386304_27386479 | 0.35 |
EVX1-AS |
EVX1 antisense RNA |
99543 |
0.05 |
chr2_151343410_151343893 | 0.35 |
RND3 |
Rho family GTPase 3 |
530 |
0.88 |
chr1_82266791_82267081 | 0.35 |
LPHN2 |
latrophilin 2 |
854 |
0.76 |
chr8_120649956_120650241 | 0.35 |
ENPP2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
922 |
0.68 |
chr2_20261532_20261778 | 0.35 |
RP11-644K8.1 |
|
9760 |
0.17 |
chr3_197105106_197105453 | 0.35 |
ENSG00000238491 |
. |
38857 |
0.16 |
chr12_3994602_3994903 | 0.35 |
PARP11 |
poly (ADP-ribose) polymerase family, member 11 |
12144 |
0.23 |
chr13_74899197_74899360 | 0.34 |
ENSG00000206617 |
. |
35927 |
0.21 |
chr1_59528139_59528464 | 0.34 |
FGGY |
FGGY carbohydrate kinase domain containing |
234009 |
0.02 |
chr7_45771537_45771728 | 0.34 |
SEPT7P2 |
septin 7 pseudogene 2 |
13011 |
0.24 |
chr7_17349805_17349956 | 0.34 |
AC003075.4 |
|
10899 |
0.22 |
chr9_129916828_129917272 | 0.34 |
ANGPTL2 |
angiopoietin-like 2 |
31888 |
0.16 |
chr10_52983888_52984147 | 0.34 |
RP11-40C11.2 |
|
21549 |
0.19 |
chr3_87040086_87040946 | 0.34 |
VGLL3 |
vestigial like 3 (Drosophila) |
247 |
0.96 |
chr17_29887718_29887925 | 0.34 |
ENSG00000207614 |
. |
806 |
0.46 |
chr6_169653019_169653284 | 0.34 |
THBS2 |
thrombospondin 2 |
905 |
0.7 |
chr5_140603012_140603165 | 0.34 |
PCDHB14 |
protocadherin beta 14 |
10 |
0.94 |
chr5_88081859_88082385 | 0.34 |
MEF2C |
myocyte enhancer factor 2C |
37483 |
0.19 |
chr8_22023419_22024083 | 0.34 |
BMP1 |
bone morphogenetic protein 1 |
951 |
0.4 |
chr5_31193803_31195028 | 0.34 |
CDH6 |
cadherin 6, type 2, K-cadherin (fetal kidney) |
558 |
0.85 |
chr4_33073977_33074128 | 0.33 |
ENSG00000265035 |
. |
464314 |
0.01 |
chr4_55096373_55096991 | 0.33 |
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
193 |
0.97 |
chr17_80970638_80970845 | 0.33 |
RP11-1197K16.2 |
|
31783 |
0.15 |
chr2_205316956_205317200 | 0.33 |
PARD3B |
par-3 family cell polarity regulator beta |
93438 |
0.1 |
chr5_129242272_129242439 | 0.33 |
CTC-575N7.1 |
|
745 |
0.66 |
chr5_119959781_119959971 | 0.33 |
PRR16 |
proline rich 16 |
7093 |
0.32 |
chr6_108025883_108026053 | 0.33 |
SCML4 |
sex comb on midleg-like 4 (Drosophila) |
27631 |
0.24 |
chr2_238322230_238322381 | 0.33 |
COL6A3 |
collagen, type VI, alpha 3 |
486 |
0.82 |
chr10_93389242_93389393 | 0.33 |
PPP1R3C |
protein phosphatase 1, regulatory subunit 3C |
3494 |
0.36 |
chr21_27011149_27011750 | 0.33 |
JAM2 |
junctional adhesion molecule 2 |
135 |
0.96 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.5 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 0.7 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
0.2 | 0.7 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.2 | 0.9 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 0.9 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.7 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.2 | 0.6 | GO:0035583 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.2 | 0.6 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.2 | 0.6 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.2 | 0.6 | GO:0060242 | contact inhibition(GO:0060242) |
0.2 | 0.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.6 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.2 | 0.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 0.5 | GO:0060596 | mammary placode formation(GO:0060596) |
0.2 | 1.2 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.2 | 0.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.4 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.1 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.1 | 1.0 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.4 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.1 | GO:0032353 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.1 | 0.8 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.4 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.3 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.1 | 0.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.2 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.1 | 0.5 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.2 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.1 | 0.1 | GO:0060433 | bronchus development(GO:0060433) |
0.1 | 0.3 | GO:0010658 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.3 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.3 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.3 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.1 | 0.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.3 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.8 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.3 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 1.1 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.8 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.4 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.2 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.3 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.5 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.1 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 1.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.2 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.1 | 0.3 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.2 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.1 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.1 | 0.7 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.3 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.1 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 1.0 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.4 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.1 | 0.1 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 0.1 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.1 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.1 | 0.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.3 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.2 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.3 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.2 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.1 | 0.1 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 1.7 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.1 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.2 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.1 | 0.5 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.1 | GO:0001660 | fever generation(GO:0001660) |
0.1 | 0.2 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.1 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.1 | 0.2 | GO:0070091 | glucagon secretion(GO:0070091) |
0.1 | 0.1 | GO:0060426 | lung vasculature development(GO:0060426) |
0.1 | 0.2 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 0.2 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.1 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.1 | GO:0032825 | regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.5 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.1 | GO:0090037 | regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 0.1 | GO:0060841 | venous blood vessel development(GO:0060841) |
0.1 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 0.2 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.2 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.2 | GO:0043113 | receptor clustering(GO:0043113) |
0.1 | 0.2 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.2 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.1 | 0.3 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.1 | GO:0061316 | negative regulation of heart induction by canonical Wnt signaling pathway(GO:0003136) negative regulation of cardioblast cell fate specification(GO:0009997) cardioblast cell fate commitment(GO:0042684) cardioblast cell fate specification(GO:0042685) regulation of cardioblast cell fate specification(GO:0042686) negative regulation of cardioblast differentiation(GO:0051892) cardiac cell fate specification(GO:0060912) canonical Wnt signaling pathway involved in heart development(GO:0061316) negative regulation of heart induction(GO:1901320) negative regulation of cardiocyte differentiation(GO:1905208) regulation of cardiac cell fate specification(GO:2000043) negative regulation of cardiac cell fate specification(GO:2000044) |
0.1 | 0.2 | GO:0045916 | negative regulation of protein processing(GO:0010955) negative regulation of complement activation(GO:0045916) negative regulation of protein maturation(GO:1903318) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.1 | GO:0045978 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.0 | 0.1 | GO:0014824 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0019049 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.0 | 0.6 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.6 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.1 | GO:1903392 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.0 | 0.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.0 | GO:0010996 | response to auditory stimulus(GO:0010996) auditory behavior(GO:0031223) |
0.0 | 0.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 0.2 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.1 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.0 | GO:1900120 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.0 | 0.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.4 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 1.1 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.0 | 0.1 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.0 | 0.1 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.0 | 0.1 | GO:0046639 | negative regulation of alpha-beta T cell differentiation(GO:0046639) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.0 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.0 | 0.3 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.6 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.4 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.0 | 0.2 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
0.0 | 0.2 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
0.0 | 0.0 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.0 | 0.2 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.1 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.1 | GO:0042053 | regulation of dopamine metabolic process(GO:0042053) |
0.0 | 0.4 | GO:0014032 | neural crest cell development(GO:0014032) |
0.0 | 0.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.2 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.0 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.2 | GO:0070875 | positive regulation of glycogen biosynthetic process(GO:0045725) positive regulation of glycogen metabolic process(GO:0070875) |
0.0 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.2 | GO:0070234 | positive regulation of lymphocyte apoptotic process(GO:0070230) positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.4 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.0 | GO:0030501 | positive regulation of bone mineralization(GO:0030501) |
0.0 | 0.1 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.0 | 0.2 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.5 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.0 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.0 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.0 | 0.0 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.0 | 0.1 | GO:0001878 | response to yeast(GO:0001878) |
0.0 | 0.2 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.3 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.1 | GO:0010171 | body morphogenesis(GO:0010171) |
0.0 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.1 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.1 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.1 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.0 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.3 | GO:0071456 | cellular response to decreased oxygen levels(GO:0036294) cellular response to oxygen levels(GO:0071453) cellular response to hypoxia(GO:0071456) |
0.0 | 0.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.1 | GO:0035412 | catenin import into nucleus(GO:0035411) regulation of catenin import into nucleus(GO:0035412) |
0.0 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.8 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.0 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.1 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) negative regulation of lipase activity(GO:0060192) |
0.0 | 0.1 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.0 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.1 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.0 | 0.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.2 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) positive regulation of calcium ion import(GO:0090280) |
0.0 | 0.2 | GO:0010092 | specification of organ identity(GO:0010092) |
0.0 | 0.2 | GO:0050922 | negative regulation of chemotaxis(GO:0050922) |
0.0 | 0.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.3 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.0 | 0.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.0 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.0 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.0 | 0.1 | GO:1903020 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.0 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.3 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.1 | GO:0048935 | peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.5 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.0 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.0 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) negative regulation of cation transmembrane transport(GO:1904063) |
0.0 | 0.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.1 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.0 | 0.3 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.1 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
0.0 | 0.1 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.2 | GO:0031272 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.4 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.3 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.3 | GO:0007520 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.0 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.1 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.1 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) positive regulation of tooth mineralization(GO:0070172) |
0.0 | 0.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.0 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.5 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.0 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.0 | 0.0 | GO:0090030 | regulation of steroid hormone biosynthetic process(GO:0090030) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.2 | GO:0050807 | regulation of synapse organization(GO:0050807) |
0.0 | 3.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 1.1 | GO:0071773 | BMP signaling pathway(GO:0030509) response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.0 | 0.0 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
0.0 | 0.1 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.0 | 0.0 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.0 | 0.0 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.0 | 0.4 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.1 | GO:0007619 | courtship behavior(GO:0007619) male courtship behavior(GO:0008049) male mating behavior(GO:0060179) |
0.0 | 0.2 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.1 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.0 | 0.1 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.0 | 0.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.0 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.0 | 0.0 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 0.0 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.0 | GO:0015793 | glycerol transport(GO:0015793) |
0.0 | 0.3 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.1 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.0 | 0.9 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.0 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.1 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.0 | 0.1 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.3 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.0 | 0.0 | GO:0061383 | trabecula formation(GO:0060343) trabecula morphogenesis(GO:0061383) |
0.0 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.2 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0043474 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.0 | 0.2 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.0 | 0.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.3 | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
0.0 | 0.1 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.0 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.1 | GO:0007625 | grooming behavior(GO:0007625) |
0.0 | 0.1 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.0 | GO:0060346 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.0 | 0.0 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.0 | 0.0 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.0 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.0 | GO:0006573 | valine metabolic process(GO:0006573) |
0.0 | 0.0 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.1 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.0 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.0 | 0.0 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.1 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.0 | 0.0 | GO:0021546 | rhombomere development(GO:0021546) |
0.0 | 0.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.0 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.0 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.0 | GO:0090196 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.0 | 0.0 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.1 | GO:0051588 | regulation of neurotransmitter transport(GO:0051588) |
0.0 | 0.1 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.0 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.1 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.0 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.0 | 0.4 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.0 | 0.1 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.0 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.0 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.0 | 0.1 | GO:0098876 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.0 | 0.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 0.0 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.0 | 0.0 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.0 | GO:0017000 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.1 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.0 | 0.1 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.4 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.0 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.0 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.1 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.1 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.0 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.0 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.0 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.2 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.0 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.1 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.0 | 0.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.0 | GO:2000573 | positive regulation of DNA biosynthetic process(GO:2000573) |
0.0 | 0.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.4 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.0 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.0 | 0.0 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.5 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.5 | 1.5 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 2.3 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 0.4 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 1.1 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.2 | 0.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.4 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.1 | 1.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.4 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.5 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.7 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.4 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 0.5 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.4 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.3 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.8 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.1 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.5 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.2 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.6 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 0.7 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 1.8 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.4 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.6 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.3 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.2 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.1 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.2 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 1.9 | GO:0044420 | extracellular matrix component(GO:0044420) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.3 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 5.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.2 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.9 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 1.7 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 1.3 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.5 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 1.1 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 1.1 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.1 | GO:0042825 | TAP complex(GO:0042825) |
0.0 | 0.3 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.0 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.2 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.8 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.2 | 0.7 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.2 | 0.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 0.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 1.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.9 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 1.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.5 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 1.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.5 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 1.3 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.3 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.5 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.1 | 1.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.1 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 3.0 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.6 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 0.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.2 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.2 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.4 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 3.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.4 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 1.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 2.4 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.4 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.1 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.2 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.0 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.4 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.1 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.0 | 0.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.0 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.3 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.5 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0046980 | tapasin binding(GO:0046980) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.1 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.1 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.0 | 0.0 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.2 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.4 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.2 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.1 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.0 | 0.0 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.1 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.0 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.0 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 4.2 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.1 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.0 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.9 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.0 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.2 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 0.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.0 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.0 | 1.1 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.0 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.0 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.1 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 5.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 4.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 1.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 1.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 5.5 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 1.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.2 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 1.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 1.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 5.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.7 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 0.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 1.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 1.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.0 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.5 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.5 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.1 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.0 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.0 | 0.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.1 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.0 | 0.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.1 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 0.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.0 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.0 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.0 | 0.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.3 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.5 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 0.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.0 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |